CoreWeave CDO logs trust share sales and conversions
CoreWeave, Inc.’s Chief Development Officer Brannin McBee reported a series of indirect transactions in Class A and Class B Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CoreWeave, Inc.’s Chief Development Officer Brannin McBee reported a series of indirect transactions in Class A and Class B Common Stock. On June 22, 2026, grantor retained annuity trusts associated with McBee converted 52,500 shares of Class B Common Stock into 52,500 shares of Class A Common Stock and sold those Class A shares in multiple open-market transactions at prices up to $119.00 per share.
The sales were effected under a Rule 10b5-1 trading plan adopted on March 5, 2026. Following these conversions and sales, the trusts continued to hold 523,705 shares of Class B Common Stock in the Canis Minor 2025 GRAT and 3,797,227 shares of Class B Common Stock in the Canis Major 2025 GRAT, all reported as indirect ownership.
Insider Trade Summary 10b5-1
Exercise and Sale: 52,500 shares ($5.84M approx. pre-tax spread)
Exercise and Sale
28 txns
Insider
McBee Brannin
Role
Chief Development Officer
Sold
52,500 shs ($5.84M)
Approx. gross sale proceeds
$5.84M
Approx. exercise cost
$0.00
Approx. pre-tax spread
$5.84M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 40,000 | $0.00 | $0.00 |
| Conversion | Class B Common Stock | 12,500 | $0.00 | $0.00 |
| Conversion | Class A Common Stock | 40,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 2,177 | $107.0531 | $233K |
| Sale | Class A Common Stock | 2,528 | $108.2424 | $274K |
| Sale | Class A Common Stock | 3,151 | $109.2096 | $344K |
| Sale | Class A Common Stock | 7,799 | $110.2748 | $860K |
| Sale | Class A Common Stock | 12,761 | $111.2298 | $1.42M |
| Sale | Class A Common Stock | 4,304 | $112.0395 | $482K |
| Sale | Class A Common Stock | 1,744 | $112.97 | $197K |
| Sale | Class A Common Stock | 1,392 | $114.5015 | $159K |
| Sale | Class A Common Stock | 1,600 | $115.4209 | $185K |
| Sale | Class A Common Stock | 1,888 | $116.4805 | $220K |
| Sale | Class A Common Stock | 320 | $117.421 | $38K |
| Sale | Class A Common Stock | 336 | $119.00 | $40K |
| Conversion | Class A Common Stock | 12,500 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 680 | $107.0529 | $73K |
| Sale | Class A Common Stock | 790 | $108.2424 | $86K |
| Sale | Class A Common Stock | 985 | $109.2093 | $108K |
| Sale | Class A Common Stock | 2,438 | $110.2747 | $269K |
| Sale | Class A Common Stock | 3,988 | $111.2299 | $444K |
| Sale | Class A Common Stock | 1,344 | $112.0397 | $151K |
| Sale | Class A Common Stock | 545 | $112.97 | $62K |
| Sale | Class A Common Stock | 435 | $114.5014 | $50K |
| Sale | Class A Common Stock | 500 | $115.4209 | $58K |
| Sale | Class A Common Stock | 590 | $116.4805 | $69K |
| Sale | Class A Common Stock | 100 | $117.421 | $12K |
| Sale | Class A Common Stock | 105 | $119.00 | $12K |
Holdings After Transaction:
Class B Common Stock — 3,797,227 contracts (Indirect, Canis Major 2025 GRAT);
Class B Common Stock — 523,705 contracts (Indirect, Canis Minor 2025 GRAT);
Class A Common Stock — 0 shares (Indirect, Canis Major 2025 GRAT);
Class A Common Stock — 0 shares (Indirect, Canis Minor 2025 GRAT)
Footnotes (15)
- F1. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
- F2. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.
- F3. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.63 to $107.62, inclusive.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.66 to $108.65, inclusive.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $109.65, inclusive.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.65, inclusive.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.66 to $111.65, inclusive.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.66 to $112.65, inclusive.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.67 to $113.58, inclusive.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.89, inclusive.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.99 to $115.98, inclusive.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.99, inclusive.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.05 to $117.76, inclusive.
- F15. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.
Key Figures
Class A shares sold: 52,500 shares
Class B shares converted: 52,500 shares
Highest reported sale price: $119.00/share
+4 more
7 metrics
Class A shares sold
52,500 shares
Indirect open-market sales on June 22, 2026
Class B shares converted
52,500 shares
Converted into Class A on June 22, 2026
Highest reported sale price
$119.00/share
One of multiple open-market sale prices
Canis Minor 2025 GRAT Class B holdings
523,705 shares
Indirect Class B ownership after transactions
Canis Major 2025 GRAT Class B holdings
3,797,227 shares
Indirect Class B ownership after transactions
Net share direction
52,500 net shares sold
Net of conversions and open-market sales
Transaction count
24 sales, 4 conversions
Aggregated across derivative and non-derivative entries
Key Terms
grantor retained annuity trust, Rule 10b5-1 trading plan, Class B Common Stock, weighted average price, +1 more
5 terms
grantor retained annuity trust financial
"The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary."
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Rule 10b5-1 trading plan regulatory
"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative conversion financial
"Conversion of derivative security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did CoreWeave (CRWV) report for Brannin McBee?
CoreWeave reported that trusts associated with Chief Development Officer Brannin McBee converted 52,500 Class B shares into 52,500 Class A shares, then sold those Class A shares in multiple open-market transactions on June 22, 2026 under a pre-arranged Rule 10b5-1 trading plan.
What CoreWeave (CRWV) holdings remain after McBee’s reported transactions?
After the June 22, 2026 transactions, the Canis Minor 2025 GRAT held 523,705 shares of Class B Common Stock and the Canis Major 2025 GRAT held 3,797,227 Class B shares, all reported as indirect ownership linked to Brannin McBee through grantor retained annuity trusts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates